QUICK CHATS - Enabling Quality and Expertise in Drug Manufacturing
Ben Reed, Vice President of Manufacturing, discusses Altasciences' unique drug manufacturing capabilities, talent acquisition, and running niche programs.
...working with Altasciences has been excellent, from both a bioanalytical, and a bioavailability study perspective. We are really impressed with their planning and execution abilities – I would not consider another provider for future work.
Read the blog
2020 has been quite a year! Each year, we strive to provide you with a more innovative, simplified, and seamless early phase drug development journey. And the past 12 months have been no exception.
Bring your talents and forward-thinking approach to Altasciences and help us develop medicines for those who need them, faster. We have a number of opportunities for you to explore.
Webinar
This webinar will focus on when and how to use cognitive assessments as a safety tool in early development studies, as well as the critical nature of assessing potential driving impairment.
Safety assessments for both small and large molecules
Clinical pharmacology trials from first-in-human to end of Phase II
From formulation development, phase I through commercial manufacturing, and ICH stability testing
As part of our full service offering or as standalone solutions
Comprehensive CRO services to support clinical and preclinical studies
This site uses cookies to store information on your computer and improve your browsing experience. By remaining on this site, you consent to the placement of these cookies. Read our Cookie Policy to learn more.
Ben Reed, Vice President of Manufacturing, discusses Altasciences' unique drug manufacturing capabilities, talent acquisition, and running niche programs.
Working as a flexible, attentive extension of your team, we offer all you need to move your molecule forward.
2019 © Altasciences. All Rights Reserved.